Maria Sharapova Receives Two-Year Suspension for Meldonium Use
She already has plans to fight back against the ruling.
The International Tennis Federation ruled on Wednesday (Jun. 8) that Maria Sharapova is suspended from playing tennis for two years after testing positive for meldoium use during the Australian Open. The ruling — made by an independent three-person panel — states that Sharapova bears “sole responsibility” and “very significant fault” for the positive test even though she did not cheat intentionally.
Sharapova released the following statement in response.
“While the tribunal concluded correctly that I did not intentionally violate the anti-doping rules, I cannot accept an unfairly harsh two-year suspension. The tribunal, whose members were selected by the ITF, agreed that I did not do anything intentionally wrong, yet they seek to keep me from playing tennis for two years. I will immediately appeal the suspension portion of this ruling to CAS, the Court of Arbitration for Sport.”
The tennis star was suspended by the ITF in March after announcing at a news conference that she failed a doping test in January. She said that she was prescribed to take the drug for medical reasons in 2006 unaware that the World Anti-Doping Agency banned athletes from its use as of Jan. 1.